State CT
Clinical Trials in Connecticut
Recruiting clinical trials with at least one study location in Connecticut. Data updated daily from ClinicalTrials.gov.
Top Conditions in Connecticut
NCT04046562 N/A
Recruiting
Pain and Weight Treatment: Development and Trial of PAW
Condition
Obesity, Adolescent
Enrollment
50 pts
Location
United States
Sponsor
Connecticut Children's Medical
NCT06491823 N/A
Recruiting
Speech Motor Learning and Retention (Aim 2)
Condition
Speech
Enrollment
120 pts
Location
United States
Sponsor
Yale University
NCT05579470 N/A
Recruiting
Expanding Medication-Assisted Therapies in Central Asia
Condition
Opioid Use Disorder
Enrollment
900 pts
Location
United States, Kazakhstan, Kyrgyzstan
Sponsor
Yale University
NCT05338151 N/A
Recruiting
Promoting Alcohol Treatment Engagement Post-hospitalization
Condition
Alcohol Use Disorder
Enrollment
450 pts
Location
United States
Sponsor
Yale University
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06963905 Phase 1, Phase 2
Recruiting
Saci Nivo Rela for TNBC
Condition
Metastatic Triple-negative Breast Cancer
Enrollment
60 pts
Location
United States
Sponsor
Yale University
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06105931 Phase 1
Recruiting
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
Condition
type1diabetes
Enrollment
15 pts
Location
United States
Sponsor
Yale University
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05195970 N/A
Recruiting
Walnuts and Colon Health
Condition
Colorectal Cancer
Enrollment
200 pts
Location
United States
Sponsor
UConn Health
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT05612594 Phase 4
Recruiting
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotra...
Condition
Sleep Apnea
Enrollment
164 pts
Location
United States
Sponsor
Yale University
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT07155174 Phase 2
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activ...
Condition
Small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Israel, Japan
Sponsor
AbbVie
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT06812390 Phase 2
Recruiting
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Condition
Cirrhosis
Enrollment
20 pts
Location
United States
Sponsor
Anahita Rabiee MD MHS
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University